Literature DB >> 30653798

Use of the IDEAL framework in the urological literature: where are we in 2018?

Michael B Tradewell1, Jacob Albersheim2, Philipp Dahm2,3.   

Abstract

OBJECTIVES: To assess uptake and application of the IDEAL principles in original surgical procedure- or device-related clinical research studies, as well as its reported relevance as characterized by secondary publications, editorials and reviews.
MATERIALS AND METHODS: IDEAL (Idea, Development, Exploration, Assessment, Long-term study) is a framework that provides stage-specific guidance for surgical innovation and represented a major advance towards raising evidential standards. We performed a comprehensive literature search of all urology-related publications citing one or more of seven key publications on IDEAL in The Lancet and BMJ using multiple databases up to 31 December 2017.
RESULTS: We identified a total of 150 urology-related manuscripts citing IDEAL, of which 83 (55.3%) were original research and 67 (44.7%) were secondary publications. Among the original research articles, 40 (48.2%) did not explicitly apply IDEAL principles or were not surgical innovation studies. The IDEAL phases of the 43 (51.8%) remaining original research studies were IDEAL, in nine (20.9%), 27 (62.8%), four (9.3%), 0 (0%), and three publications (7.0%), respectively. Across IDEAL stages, 30 (75.0%) studies were prospective, 29 (85.3%) reported ethical oversight, and 39 (90.7%) captured treatment-related harms. None of the studies collected information on physician experience.
CONCLUSIONS: The IDEAL framework has found widespread adoption in the urology literature as witnessed by a large number of original manuscripts and secondary publications citing IDEAL; however, its application is largely limited to the early stages of surgical innovation, frequently with inappropriate and incomplete implementation. Further efforts are needed to guide investigators in the optimal use of the IDEAL framework as it relates to surgical innovation in urology.
© 2019 The Authors BJU International © 2019 BJU International Published by John Wiley & Sons Ltd.

Keywords:  IDEAL; evidence-based medicine; surgical innovation; surgical trials

Mesh:

Year:  2019        PMID: 30653798     DOI: 10.1111/bju.14676

Source DB:  PubMed          Journal:  BJU Int        ISSN: 1464-4096            Impact factor:   5.588


  4 in total

Review 1.  Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.

Authors:  Juan Va Franco; Jae Hung Jung; Mari Imamura; Michael Borofsky; Muhammad Imran Omar; Camila Micaela Escobar Liquitay; Shamar Young; Jafar Golzarian; Areti Angeliki Veroniki; Luis Garegnani; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2021-07-15

Review 2.  The IDEAL framework in neurosurgery: a bibliometric analysis.

Authors:  Helen C U Ota; Brandon G Smith; Alexander Alamri; Faith C Robertson; Hani Marcus; Allison Hirst; Marike Broekman; Peter Hutchinson; Peter McCulloch; Angelos Kolias
Journal:  Acta Neurochir (Wien)       Date:  2020-07-10       Impact factor: 2.216

3.  Solo-surgeon pure laparoscopic donor nephrectomy using passive camera holder: IDEAL stage 2a study.

Authors:  Dong Hyeon An; Jae Hyeon Han; Myoung Jin Jang; Joomin Aum; Yu Seon Kim; In Gab Jeong; Bumsik Hong; Dalsan You
Journal:  BMC Urol       Date:  2022-03-25       Impact factor: 2.264

Review 4.  Newer Minimally Invasive Treatment Modalities to Treat Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia.

Authors:  Philipp Dahm; Roderick MacDonald; Lauren McKenzie; Jae Hung Jung; Nancy Greer; Timothy Wilt
Journal:  Eur Urol Open Sci       Date:  2021-02-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.